What Is the First-Line Treatment for Viral Encephalitis?

Viral encephalitis is a neurological emergency. The priority is to begin effective treatment immediately — before a definitive diagnosis is in hand — to reduce the risk of serious sequelae or death.

Clinical Urgency

Act before confirmation

Evidence-based guidance is explicit: treatment must be started in all patients with suspected viral encephalitis as soon as possible, while diagnostic studies are still pending. Delay in initiation is associated with worse outcomes.

Treatment Overview

The first-line protocol centres on antiviral therapy — specifically acyclovir — which is initiated empirically across patient populations. Regimens differ by age group and renal function status. The full protocol defines these distinctions in detail.

Instant Access to Structured Evidence-Based Regimens

References

Acyclovir should be initiated in all patients with suspected encephalitis, pending results of diagnostic studies (A-III).
Because the earlier that treatment is started for herpes simplex encephalitis, the less likely that death or serious sequelae will result, acyclovir (10 mg/kg intravenously every 8 h in children and adults with normal renal function; 20 mg/kg intravenously every 8 h in neonates) should be initiated in all patients with suspected encephalitis as soon as possible, pending results of diagnostic studies.

DOI: 10.1086/589747

View source ↗